Lafayette General Medical Center is looking for participants to be part of a study into B-cell indolent non-Hodgkin's lymphoma.

They are looking for men and women 18 and older with the disease.

The focus of the research will be to looking into medication for adult patients who have already been treated for indolent non-Hodgkin's lymphoma.

LGMC reports this is a Phase III clinical trial, meaning it's a final study of the safety and reliability of drugs being tested.

LGMC points out that they do clinical trials and studies for a variety of reasons:

  • Improve patient care
  • Disease prevention
  • Access to newer treatments and drugs that otherwise might not be available
  • Knowledge about the best ways to treat cancer
  • Empower Clinical trials also empower a patient who may not be responding ideally to treatment to make his or her own decision

LGMC says patients will be given full instruction on the potential risks and benefits of taking part in the clinical trial.  They will also follow up with progress reports and follow-up care.

For more information on this and other clinical trials available at Lafayette General Medical Center, call (337) 289-8658.